NLRP3 and hepatocellular carcinoma: Activation of specific inflammasome complexes, such as the NLRP3 inflammasome, has been observed in liver cancer and has been associated with tumor growth, angiogenesis, and metastasis [17,18], but its role has not been analyzed in patients under HCC treatments.